Non-invasive Cranial Electrical Stimulation for Mealtime Anxiety in Adults With Eating Disorders
Eligible age
18–30 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The study is to evaluate the feasibility of using a non-invasive brain stimulation device in a sample of inpatients with eating disorders (ED). The study will help researchers evaluate whether their device protocol is practical for eating disorder inpatients as a way to manage eating disorder and anxiety symptoms. A secondary aim of the study is to evaluate preliminary effectiveness of the protocol for reducing pre-meal anxiety during the treatment, and explore effects on eating disorder symptoms over the course of the inpatient admission.
Sponsor: Rogers Behavioral Health
You may qualify if…
- ✓ 1. Age 18-30 years old at the time of enrollment
- ✓ 2. Enrolled in Rogers Behavioral Health Eating Disorder Recovery Program Inpatient Unit at the Oconomowoc, WI clinic location
- ✓ 3. Have a primary diagnosis of any DSM-5 eating disorder (anorexia nervosa, bulimia nervosa, binge eating disorder, avoidant/restrictive food intake disorder, other specified feeding or eating disorder)
- ✓ 4. Ability to communicate effectively using written and spoken English
- ✓ 5. Participant is eligible for mealtime anxiety support based on:
- ✓ ≤ 75% meal plan compliance
- ✓ Visible anxiety/distress during program meals
- ✓ Engagement in compensatory behaviors or self-harm before, during, or after meals, or medical staff judge patient to be at risk of same
You may not qualify if…
- ✕ 1. Metal in the body of any kind (e.g., braces, pacemakers, metal plates or screws, intracranial electrodes, implanted devices/defibrillators, prostheses)
- ✕ 2. Currently taking medication that reduces seizure threshold (e.g., clomipramine)
- ✕ 3. Cranial pathologies (e.g., holes, plates)
- ✕ 4. History of seizure or black-out concussion
- ✕ 5. Pregnancy
- ✕ 6. Risk of suicide/self-harm by self-strangulation with cranial electrotherapy stimulation (CES) device judged by study medical staff
- ✕ 7. Participant calibrates to a stimulation level below 200 microampere (μA)
Where it's recruiting
Oconomowoc
Source: ClinicalTrials.gov · NCT07017322 · last updated 2025-06-12